NOVEN SUBMITS NEW DRUG APPLICATION FOR INVESTIGATIONAL NON-HORMONAL THERAPY FOR MENOPAUSAL VASOMOTOR SYMPTOMS Miami, FL and New York, NY, August 29, 2012 -- Noven Pharmaceuticals, Inc., a wholly-owned subsidiary of Hisamitsu Pharmaceutical Co., Inc., today announced that it has submitted to the U.S. Food & Drug Administration a New Drug Application (NDA) seeking approval to market...
↧